Virtual reality and podcasts are two innovative tools that can help captivate your audience and differentiate your healthcare brand. By utilizing these cutting-edge technologies, you can stay ahead of the competition and create more engaging marketing campaigns.
Greg Walthour, Author at MedCity News medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
The new year always brings hope, but this January that hope was palpable for the over 50 million people with Alzheimer’s Disease (AD) worldwide, their families, friends, and clinicians when the Food and Drug Administration (FDA) granted accelerated approval for Leqembi to treat mild cognitive impairment or dementia due to AD. For the first time, a therapy will be available to slow the otherwise relentless progress of AD. Compared with prior medications in the same class, the clinical trial results that led to the FDA’s approval of Leqembi reveal significant, clinically demonstrable benefits – slowing disease progression by about 30%. While it is unclear how impactful Leqembi may be for each individual and the benefits will need to be balanced against risks and costs, these findings mark a true inflection point in the battle against AD. They also underscore the need to implement a long overdue transformation of our healthcare system and evolve clinical practices to ensure early d
Dr Alvaro Pascual-Leone, Author at MedCity News medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Three months after Alentis Therapeutics’ lead program posted positive Phase 1 data, the biotech has raised cash to advance that program to mid-stage testing in fibrosis. The Series C financing will also support a cancer drug candidate ready to start human testing.